Rice University research finds GLP-1 users face greater social stigma
Updated
Updated · SciTechDaily · May 8
Rice University research finds GLP-1 users face greater social stigma
12 articles · Updated · SciTechDaily · May 8
The International Journal of Obesity study, led by Erin Standen, found participants rated GLP-1 users more negatively than people who lost weight through diet and exercise or not at all.
It also found weight regain after stopping GLP-1 drugs or after dieting drew harsher judgment than maintained weight loss, with discontinuation often linked to cost, insurance limits or side effects.
The findings matter as GLP-1 use expands, with an estimated one in eight US adults having tried the drugs, because stigma can increase stress, deter medical care and affect health decisions.
As GLP-1s are found to treat addiction, will the 'easy way out' stigma finally be overcome?
If obesity is a disease, why is its medical treatment judged more harshly than the disease itself?
Judged for the Cure: The New Stigma Facing GLP-1 Weight Loss Drug Users in America
Overview
This report highlights that people who use GLP-1 medications for weight loss face strong social stigma, often being judged more harshly than those who lose weight through diet and exercise. The method of weight loss itself has become a new focus for criticism, with many viewing GLP-1s as an 'easy way out.' This stigma does not disappear with weight loss and can even intensify if individuals regain weight after stopping treatment. The negative judgment leads to increased stress and can cause people to delay seeking medical care, showing how deeply weight stigma affects both personal well-being and health outcomes.